Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone.
Open accessThe DOI matches its Crossref record; 45 of the 47 references it cites were found in a registry or an index.
Abstract
Paget disease of bone (PDB) is a common disorder characterized by focal and disorganized increases of bone turnover. Genetic factors are important in the pathogenesis of PDB. We and others recently mapped the third locus associated with the disorder, PDB3, at 5q35-qter. In the present study, by use of 24 French Canadian families and 112 unrelated subjects with PDB, the PDB3 locus was confined to approximately 300 kb. Within this interval, two disease-related haplotype signatures were observed in 11 families and 18 unrelated patients. This region encoded the ubiquitin-binding protein sequestosome 1 (SQSTM1/p62), which is a candidate gene for PDB because of its association with the NF-kappaB pathway. Screening SQSTM1/p62 for mutations led to the identification of a recurrent nonconservative change (P392L) flanking the ubiquitin-associated domain (UBA) (position 394-440) of the protein that was not present in 291 control individuals. Our data demonstrate that two independent mutational events at the same position in SQSTM1/p62 caused PDB in a high proportion of French Canadian patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most recently, mutations in the sequestosome 1 gene, a scaffold protein in the NF-B signaling pathway, have been demonstrated in some cases of familial and sporadic PDB (399 -404).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [403]
In the citing paper
“SQSTM1 mutations are not only a rare cause of ALS-FTD, accounting for ~1-3.5% of cases with or without family history [123–125], but also Paget’s disease of bone (PDB), a chronic and progressive skeletal disorder characterized by disorganized bone turnover [126,127], and inclusion body myositis (IBM) [128].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [126]
Citations
Cites
SMART, a simple modular architecture research tool: Identification of signaling domains
Schultz, J., Milpetz, F., Bork, P., & Ponting, C. P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.5857 · Cited by 3,599 · cited 4×
“Cosegregation of the P392L variant with the phenotype, its absence in 86 spouses and 205 individuals from the general population, the nonconservative nature of the amino acid substitution, and the conservation of the UBA domain, including the P392 residue, among other species (mouse and rat) provided support for the i…”
BackgroundInfluentialA comprehensive genetic map of the human genome based on 5,264 microsatellites
Dib, C., Fauré, S., Fizames, C., Samson, D., Drouot, N., Vignal, A., Millasseau, P., Marc, S., Kazan, J., Seboun, E., et al. (1996) · Nature · doi:10.1038/380152a0 · Cited by 2,928 · cited 1×
“markers (Dib et al. 1996), present within this interval, using an ePCR approach (Schuler 1998).”
MethodSelf-citationHsu, H., Lacey, D. L., Dunstan, C. R., Solovyev, I., Colombero, A., Timms, E., Tan, H.-L., Elliott, G., Kelley, M. J., Sarosi, I., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3540 · Cited by 1,636 · cited 1×
“Osteoclast formation and activation involve the receptor activator of NF-kB (RANK) pathway, a tumor-necrosis factor (TNF) family member (Hsu et al. 1999).”
BackgroundThe staden sequence analysis package
Staden, R. (1996) · Molecular Biotechnology · doi:10.1007/bf02900361 · Cited by 1,263 · cited 1×
“Both strands were analyzed using STADEN package 1.1 (Staden 1996).”
MethodInfluentialSobel, E. M., & Lange, K. L. (1996) · PubMed Central · Cited by 1,176
Principles and Practice of Endocrinology and Metabolism.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-816_4 · Cited by 803
Naito, A., Azuma, S., Tanaka, S., Miyazaki, T., Takaki, S., Takatsu, K., Nakao, K., Nakamura, K., Katsuki, M., Yamamoto, T., et al. (1999) · Genes to Cells · doi:10.1046/j.1365-2443.1999.00265.x · Cited by 635 · cited 6×
“1999), and TRAF6-deficient mice exhibit severe osteopetrosis and are defective in osteoclast formation because of impaired signaling induced by RANK (Naito et al. 1999).”
BackgroundInfluentialMutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis
Hughes, A. E., Ralston, S. H., Marken, J., Bell, C., MacPherson, H., Wallace, R. G. H., van Hul, W., Whyte, M. P., Nakatsuka, K., Hovy, L., et al. (2000) · Nature Genetics · doi:10.1038/71667 · Cited by 481 · cited 1×
“Activating mutations of the TNFRSF11A gene encoding this receptor have been found to be responsible for FEO and rare cases of early-onset familial PDB (Hughes et al. 2000).”
BackgroundThe atypical PKC-interacting protein p62 channels NF-kappa B activation by the IL-1-TRAF6 pathway
Sanz, L. (2000) · The EMBO Journal · doi:10.1093/emboj/19.7.1576 · Cited by 436 · cited 7×
“The functional importance of SQSTM1/p62 in NF-kB activation has been further highlighted by the observation that its depletion severely abrogated NF-kB activation through the TNFa or IL-1 pathways (Sanz et al. 1999, 2000).”
BackgroundInfluentialThe interaction of p62 with RIP links the atypical PKCs to NF-kappa B activation
Sanz, L. (1999) · The EMBO Journal · doi:10.1093/emboj/18.11.3044 · Cited by 410 · cited 7×
“The functional importance of SQSTM1/p62 in NF-kB activation has been further highlighted by the observation that its depletion severely abrogated NF-kB activation through the TNFa or IL-1 pathways (Sanz et al. 1999, 2000).”
BackgroundInfluential
Research works printed but not linked: 1
- Glaser, 1999, Intragenic single nucleotide polymorphism haplotype analysis of SUR1 mutations in familial hyperinsulinism, Hum Mutat, 14, 23, 10.1002/(SICI)1098-1004(1999)14:1<23::AID-HUMU3>3.0.CO;2-# · doi:10.1002/(sici)1098-1004(1999)14:1<23::aid-humu3>3.0.co;2-#
Cited by
Items 201–300 of 563
On Behalf of the GenePage Project, Falchetti, A., Stefano, M. D., Marini, F., Ortolani, S., Ulivieri, F. M., Bergui, S., Masi, L., Cepollaro, C., Benucci, M., et al. (2008) · Calcified Tissue International · doi:10.1007/s00223-008-9192-8 · Cited by 53
“SNP haplotyping using two known polymorphisms in exon 6, C916T/Asp292Asp (RefSNP ID rs4935) and G976A/ Arg312Arg (RefSNP ID rs4797) [ 4 , 16], and two known polymorphisms in the 3 0 UTR, C2503T (RefSNP ID rs10277)”
BackgroundMethodClinical and Genetic Advances in Paget’s Disease of Bone: a Review
Alonso, N., Calero‐Paniagua, I., & del Pino‐Montes, J. (2016) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-016-9226-0 · Cited by 52
“…Italian, New Zealand, USA (mixed European descent), British, Netherlands, Australian, Chinese, Polish-American, Irish-Italian, African-American Laurin et al., 2002 [39]; Falchetti et al., 2004 [54]; Cundy et al., 2011 [135]; Johnson-Pais et al., 2003 [55]; Hocking et al., 2002 [51];…”
BackgroundSelby, P. L., Davies, M., & MEE, A. P. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060805 · Cited by 55
“A strong familial component to the disorder has long been recognized,((10)) and recent evidence has identified a group of mutations in the sequestosome 1/p62 gene (SQSTM1) as a possible cause of Paget’s disease.((11,12)) The sequestosome 1/p62 gene encodes a component of the NF- signaling pathway,((13)) and the import…”
BackgroundInfluentialFeng, Y., Zhao, H., Luderer, H. F., Epple, H., Faccio, R., Ross, F. P., Teitelbaum, S. L., & Longmore, G. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607399200 · Cited by 54
Modifications in P62 occur due to proteasome inhibition in alcoholic liver disease
Bardag-Gorce, F., Francis, T., Nan, L., Li, J., He Lue, Y., French, B. A., & French, S. W. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.04.020 · Cited by 43
Sequestosome 1/p62: across diseases
Geetha, T., Viswaprakash, N., Sycheva, M., & Babu, J. R. (2012) · Biomarkers · doi:10.3109/1354750x.2011.653986 · Cited by 45
“…2000). p62 harbors an amino terminal PB1 domain with an SH2 binding domain and an acidic interaction domain (AID) that binds the atypical PKC (aPKC) (Laurin et al. 2002), a ZZ finger, a binding site for the RING-finger protein tumor necrosis factor (TNF) receptor-associated factor 6 (TRAF6),…”
BackgroundResultInfluentialAutophagy-related cell death by pan-histone deacetylase inhibition in liver cancer
Fazio, P. D., Waldegger, P., Jabari, S., Lingelbach, S., Montalbano, R., Ocker, M., Slater, E. P., Bartsch, D. K., Illig, R., Neureiter, D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8585 · Cited by 46
“Mutation of SQSTM1 is linked to Paget’s disease by causing abnormal bone turnover that results in arthritis, bone deformation and nerve injury [12].”
BackgroundThe unfolding spectrum of inherited distal myopathies
Milone, M., & Liewluck, T. (2018) · Muscle & Nerve · doi:10.1002/mus.26332 · Cited by 45
“SQSTM1 mutations with variable penetrance link to Paget disease of bone and more recently to ALS and frontotemporal dementia.(88,89) SQSTM1 mutations were reported in distal myopathy patients, but these patients were later found to carry also the TIA1 p.”
BackgroundComprehensive Genetic Analysis of a Hungarian Amyotrophic Lateral Sclerosis Cohort
Tripolszki, K., Gampawar, P. G., Schmidt, H., Nagy, Z. F., Nagy, D., Klivènyi, P., Engelhardt, J. I., & Széll, M. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00732 · Cited by 50
“Variants of the SQSTM1 gene were originally reported in Paget’s disease of bone (Laurin et al., 2002).”
BackgroundGenetics of frontotemporal lobar degeneration: An up-date and diagnosis algorithm
Ber, I. L. (2013) · Revue Neurologique · doi:10.1016/j.neurol.2013.07.014 · Cited by 56
Measles virus nucleocapsid protein increases osteoblast differentiation in Paget’s disease
Teramachi, J., Nagata, Y., Mohammad, K. S., Inagaki, Y., Ohata, Y., Guise, T. A., Michou, L., Brown, J. P., Windle, J. J., Kurihara, N., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci82012 · Cited by 52
Self-citationNeuroinflammation in Amyotrophic Lateral Sclerosis: Role of Redox (dys)Regulation
D’Ambrosi, N., Cozzolino, M., & Carrì, M. T. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7271 · Cited by 47
Mitsui, S., Otomo, A., Nozaki, M., Ono, S., Sato, K., Shirakawa, R., Adachi, H., Aoki, M., Sobue, G., Shang, H., et al. (2018) · Molecular Brain · doi:10.1186/s13041-018-0373-8 · Cited by 49
“SQSTM1 mutations have originally been identified in Paget disease of bone [9].”
BackgroundWeihl, C. C. (2011) · Current Alzheimer Research · doi:10.2174/156720511795563773 · Cited by 50
Autophagy in motor neuron disease: Key pathogenetic mechanisms and therapeutic targets
Mis, M. S. C., Brajkovic, S., Frattini, E., Fonzo, A. D., & Corti, S. P. (2016) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2016.01.012 · Cited by 49
Chung, P. Y. J., Beyens, G., Riches, P. L., Wesenbeeck, L. V., de Freitas, F., Jennes, K., Daroszewska, A., Fransén, E., Boonen, S., Geusens, P., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.162 · Cited by 53
“Until now, only one PDB-causing gene has been identified: the sequestosome1 gene (SQSTM1; MIM 601530), located in the PDB3 region on chromosome 5q35.((34,42,43)) To date, 23 SQSTM1mutations have been found in 28.”
BackgroundAutophagy: A Friend or Foe in Allergic Asthma?
Theofani, E., & Xanthou, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126314 · Cited by 50
“Paget disease of the bone and amyotrophic lateral sclerosis are linked to mutations in the P62 receptor [25].”
BackgroundMechanisms of Disease: genetics of Paget's disease of bone and related disorders
Daroszewska, A., & Ralston, S. H. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0172 · Cited by 44
Paget’s disease: a review of the epidemiology, etiology, genetics, and treatment
Banaganapalli, B., Fallatah, I., Alsubhi, F., Shetty, P. J., Awan, Z. A., Elango, R., & Shaik, N. A. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1131182 · Cited by 48
“However, even among patients with the same mutation and within the same family, clinical heterogeneity is reported (Laurin et al., 2002) (Gennari et al.”
BackgroundA neurodegenerative disease landscape of rare mutations in Colombia due to founder effects
Acosta‐Uribe, J., Aguillon, D. F., Cochran, J. N., Giraldo, M., Madrigal, L., Killingsworth, B. W., Singhal, R., Labib, S., Alzate, D., Velilla, L. M., et al. (2022) · Genome Medicine · doi:10.1186/s13073-022-01035-9 · Cited by 44
Insights into the pathogenesis of Paget's disease
Roodman, G. D. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05214.x · Cited by 40
Layfield, R., Ciani, B., Ralston, S. H., Hocking, L. J., Sheppard, P. W., Searle, M. S., & Cavey, J. R. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320728 · Cited by 47
Chung, P. Y. J., Beyens, G., Guañabens, N., Boonen, S., Papapoulos, S. E., Karperien, M., Eekhoff, E. M. W., Wesenbeeck, L. V., Jennes, K., Geusens, P., et al. (2008) · Calcified Tissue International · doi:10.1007/s00223-008-9137-2 · Cited by 44
“The frequency of SQSTM1 mutations in cases without a proven PDB family history (so-called sporadic PDB) is much lower, ranging from 2.4% in the Dutch population to 9.3% in the British population [ 22 , 31, 32, 34, 43, 45, 46, 48].”
BackgroundMethodResultInfluentialThe Loss of Profilin 1 Causes Early Onset Paget's Disease of Bone
di Carlo, F. S., Pazzaglia, L., Esposito, T., & Gianfrancesco, F. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3964 · Cited by 40
“individualswith the uncomplicated formof PDB, resulting in a dysregulation of NF-κB signaling.((13,14)) Moreover, we have recently”
Rousière, M., Michou, L., Cornélis, F., & Orcel, P. (2003) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2003.09.003 · Cited by 45
Lucas, G., Mehta, S. G., Hocking, L. J., Stewart, T. L., Cundy, T., Nicholson, G. C., Walsh, J. P., Fraser, W. D., Watts, G. D. J., Ralston, S. H., et al. (2005) · Bone · doi:10.1016/j.bone.2005.07.014 · Cited by 45
Role of p62/SQSTM1 beyond autophagy: a lesson learned from drug‐induced toxicity in vitro
Alegre, F., Moragrega, Á. B., Polo, M., Martí-Rodrigo, A., Esplugues, J. V., Blas‐García, A., & Apostolova, N. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14093 · Cited by 43
“, 2004), bone diseases (Laurin et al., 2002) and neuronal disorders (Rea et al.”
BackgroundThe molecular pathogenesis of Paget disease of bone
Layfield, R. (2007) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399407000464 · Cited by 39
Rea, S., & Foster, A. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.284977 · Cited by 37
“Mutations in the SQSTM1 gene are commonly identified in Paget’s disease of bone (PDB) (Laurin et al., 2002; Falchetti et al., 2004; Hocking et al., 2004), but have more recently been identified in both ALS and FTLD patients (Fecto et al.”
BackgroundImmune diseases caused by mutations in kinases and components of the ubiquitin system
Cohen, P. (2014) · Nature Immunology · doi:10.1038/ni.2892 · Cited by 44
Cundy, T., & Reid, I. R. (2011) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2011.09.026 · Cited by 45
Giant cell tumor complicating Paget disease of long bone
Hoch, B. L., Hermann, G., Klein, M. J., Abdelwahab, I. F., & Springfield, D. S. (2007) · Skeletal Radiology · doi:10.1007/s00256-007-0310-x · Cited by 37
“More recently, mutations in the gene encoding sequestosome 1 (SQSTM1/p62) have been identified in patients with familial and sporadic Paget disease [16].”
BackgroundEpidemiogenetic study of French families with Paget's disease of bone
Michou, L., Collet, C., Morissette, J., Audran, M., Thomas, T., Gagnon, É., Launay, J., Laplanche, J., Brown, J. P., & Orcel, P. (2011) · Joint Bone Spine · doi:10.1016/j.jbspin.2011.07.005 · Cited by 39
“[6] Laurin N, Brown JP, Morissette J, et al.”
BackgroundMethodInfluentialSelf-citationRare Inherited forms of Paget’s Disease and Related Syndromes
Ralston, S. H., & Taylor, J. P. (2019) · Calcified Tissue International · doi:10.1007/s00223-019-00520-5 · Cited by 40
Molecular insights into an ancient form of Paget’s disease of bone
Shaw, B., Burrell, C. L., Green, D., Navarro-Martinez, A., Scott, D., Daroszewska, A., Hof, R. V., Smith, L. G., Hargrave, F., Mistry, S. C., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820556116 · Cited by 43
“Such variants impact p62 in a domain-specific manner, generally being associated with missense and truncating mutations within the C-terminal ubiquitin-associated (UBA) domain (residues 387–436) (9, 10).”
BackgroundAl-Rashid, M., Ramkumar, D. B., Raskin, K. A., Schwab, J. H., Hornicek, F. J., & Lozano‐Calderón, S. A. (2015) · Orthopedic Clinics of North America · doi:10.1016/j.ocl.2015.06.008 · Cited by 39
Systematic assessment of the human osteoblast transcriptome in resting and induced primary cells
Grundberg, E., Brändström, H., Lam, K. C. L., Gurd, S., Ge, B., Harmsen, E., Kindmark, A., Ljunggren, Ö., Mallmin, H., Nilsson, O., et al. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.00028.2008 · Cited by 43
“The Sequestosome 1 gene, SQSTM1, recently associated with predisposition to Paget disease (30), is the most exaggerated example of abnormal bone remodeling.”
BackgroundLee, B., Kim, Y. H., Lee, W., Choi, H. Y., Lee, J., Kim, J., Mai, D. N., Jung, S. F., Kwak, M. S., & Shin, J. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.09.024 · Cited by 34
p38 mitogen-activated protein kinase plays a key role in regulating MAPKAPK2 expression
SUDO, T., Kawai, K., Matsuzaki, H., & Osada, H. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.063 · Cited by 39
Autophagy Dysfunction in ALS: from Transport to Protein Degradation
Cozzi, M., & Ferrari, V. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02029-3 · Cited by 39
Kovacs, G. G., van der Zee, J., Hort, J., Kristoferitsch, W., Leitha, T., Höftberger, R., Ströbel, T., Van Broeckhoven, C., & Matej, R. (2016) · Neuropathology · doi:10.1111/neup.12233 · Cited by 34
Lei, L., Wu, Z., & Winklhofer, K. F. (2020) · Matrix Biology · doi:10.1016/j.matbio.2020.11.003 · Cited by 34
Emerging strategies and therapies for treatment of Paget’s disease of bone
Brown, J. P., & Michou, L. (2011) · Drug Design Development and Therapy · doi:10.2147/dddt.s11306 · Cited by 49
“Surprisingly, Dickkopf-1 RNA and protein levels are increased in pagetic osteoblast and stromal cells, 2 Powered by TCPDF (www.tcpdf.org) giving new insights into the role of the osteoblast in PDB.”
InfluentialSelf-citationGoode, A., Long, J., Shaw, B., Ralston, S. H., Visconti, M. R., Gianfrancesco, F., Esposito, T., Gennari, L., Merlotti, D., Rendina, D., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.03.006 · Cited by 37
“This is an open access article under protein were identified [2,3].”
BackgroundP62: An emerging oncotarget for osteolytic metastasis
Zhang, J., Yang, Z., & Dong, J. (2016) · Journal of bone oncology · doi:10.1016/j.jbo.2016.01.003 · Cited by 37
Pensato, V., Magri, S., Bella, E. D., Tannorella, P., Bersano, E., Sorarú, G., Gatti, M., Ticozzi, N., Taroni, F., Lauria, G., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020412 · Cited by 38
A nonsynonymous TNFRSF11A variation increases NFκB activity and the severity of Paget's disease
Gianfrancesco, F., Rendina, D., Stefano, M. D., Mingione, A., Esposito, T., Merlotti, D., Gallone, S., Magliocca, S., Goode, A., Formicola, D., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.542 · Cited by 39
Extra-motor abnormalities in amyotrophic lateral sclerosis: another layer of heterogeneity
McCombe, P., Wray, N. R., & Henderson, R. D. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1273772 · Cited by 40
“SOD1 Superoxide dismutase, soluble Yes – AD [14] Extremely rare No SQSTM1 Sequestosome 1 Yes [15] Yes (associated with TDP43 pathology) [36] Yes – Distal myopathy, Paget’s disease of bone [37,38]”
BackgroundSequestosome 1 (SQSTM1) Mutations in Paget’s Disease of Bone from the United States
Rhodes, E. C., Johnson‐Pais, T. L., Singer, F. R., Ankerst, D. P., Bruder, J., Wisdom, J. H., Hoon, D. S. �., Lin, E., Bone, H. G., Simcic, K. J., et al. (2008) · Calcified Tissue International · doi:10.1007/s00223-008-9114-9 · Cited by 36
“Pagetic kindreds to chromosome 5q35, Laurin et al. (2002) [ 13 ] discovered a C to T (P392L) transition in exon 8 at position 1215 in the SQSTM1 gene sequence that causes a proline to leucine change in the ubiquitin-binding associated (UBA) domain of the protein.”
BackgroundMethodResultInfluentialSreedharan, J., Blakeney, I., & Brown, R. H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813866-3.00020-5 · Cited by 32
Michou, L., Morissette, J., Gagnon, É., Marquis, A., Dellabadia, M., Brown, J. P., & Siris, E. S. (2010) · Bone · doi:10.1016/j.bone.2010.11.004 · Cited by 34
“Exons 7 and 8 and exon–intron boundaries within the SQSTM1 gene were PCR amplified using previously reported primers and protocols [6].”
BackgroundMethodInfluentialSelf-citationGenetic determinants of Paget's disease of bone
Ralston, S. H., & Albagha, O. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06228.x · Cited by 36
New ALS‐Related Genes Expand the Spectrum Paradigm of Amyotrophic Lateral Sclerosis
Sabatelli, M., Marangi, G., Conte, A., Tasca, G. A., Zollino, M., & Lattante, S. (2016) · Brain Pathology · doi:10.1111/bpa.12354 · Cited by 33
“The gene was identified using a candidate gene approach in 13 families linked to chromosome 9, where 82% of individuals had myopathy, 49% had PDB and 30% had early-onset FTD (115).”
BackgroundInfluentialVallet, M., Soares, D. C., Wani, S., Sophocleous, A., Warner, J. P., Salter, D. M., Ralston, S. H., & Albagha, O. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv068 · Cited by 36
“Mutations have so far been identified in the SQSTM1 gene as a cause of the disease (7,8) and these occur in up to 40% of patients with familial PDB and up to 10% of those without a fam-”
BackgroundEnvironmental factors associated with familial or non-familial forms of Paget's disease of bone
Audet, M.-C., Jean, S., Beaudoin, C., Guay-Bélanger, S., Dumont, J., Brown, J. P., & Michou, L. (2016) · Joint Bone Spine · doi:10.1016/j.jbspin.2016.11.010 · Cited by 30
Self-citationEvolution of Paget's disease of bone in adults inheriting SQSTM 1 mutations
Cundy, T., Rutland, M. D., Naot, D., & Bolland, M. J. (2015) · Clinical Endocrinology · doi:10.1111/cen.12741 · Cited by 35
Paget disease of bone: Diagnosis and drug therapy
Seton, M. (2013) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.80a.12142 · Cited by 31
Clinical and Cellular Phenotypes Associated With Sequestosome 1 (SQSTM1) Mutations
Leach, R. J., Singer, F. R., Ench, Y., Wisdom, J. H., Pina, D. S., & Johnson-Pais, T. L. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.06s208 · Cited by 29
“To date, a total of 11 mutations have been identified, with the most common being the P392L, which was the original mutation found by Laurin et al.(4) in the French-Canadian population.”
BackgroundTargeting metastasis in paediatric bone sarcomas
Bull, E. C., Singh, A., Harden, A. M., Soanes, K., Habash, H., Toracchio, L., Carrabotta, M., Schreck, C., Shah, K. M., Riestra, P. V., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02365-z · Cited by 42
“For example, childhood osteosarcomas harbour TP53 and RB1 driver mutations whereas adult osteosarcomas are usually secondary to SQSTM1 positive Paget’s disease of bone [15–19] or radiation exposure [20, 21]).”
A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg
Abelson, A. G. (2008) · Current Medical Research and Opinion · doi:10.1185/030079908x260899 · Cited by 28
Genetics of Paget’s disease of bone
Albagha, O. (2015) · BoneKEy Reports · doi:10.1038/bonekey.2015.125 · Cited by 34
Mutations in Profilin 1 Cause Early-Onset Paget's Disease of Bone With Giant Cell Tumors
Wei, Z., Li, S., Tao, X., Zhu, G., Sun, Z., Wei, Z., Jiao, Q., Zhang, H., Chen, L., Li, B., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4275 · Cited by 32
Acetylation of p62 regulates base excision repair through interaction with APE1
Li, M., Xiong, J., Yang, L., Huang, J., Zhang, Y., Liu, M., Wang, L., Ji, J., Zhao, Y., Zhu, W., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111116 · Cited by 28
SQSTM1-NUP214: a new gene fusion in adult T-cell acute lymphoblastic leukemia
Gorello, P., Starza, R. L., Giacomo, D. D., Messina, M., Puzzolo, M. C., Crescenzi, B., Santoro, A., Chiaretti, S., & Mecucci, C. (2010) · Haematologica · doi:10.3324/haematol.2010.029769 · Cited by 28
Chung, P. Y. J., Beyens, G., de Freitas, F., Boonen, S., Geusens, P., Vanhoenacker, F. M. H. M., Verbruggen, L., Offel, J. V., Goemaere, S., Zmierczak, H., et al. (2011) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.03.021 · Cited by 34
Diagnosis and treatment of Paget's disease of bone
Josse, R. G., Hanley, D. A., Kendler, D. L., Ste‐Marie, L., Adachi, J. D., & Brown, J. P. (2007) · Clinical and investigative medicine · doi:10.25011/cim.v30i5.2897 · Cited by 28
Self-citationIs Paget’s disease of bone disappearing?
Cundy, T. (2006) · Skeletal Radiology · doi:10.1007/s00256-006-0119-z · Cited by 28
Zach, F., Polzer, F., Mueller, A., & Gessner, A. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002449 · Cited by 31
“However, the molecular mechanisms linking p62 point mutations or its complete ablation to Paget’s disease in humans or Paget’s disease–like observations in mice still remain incompletely understood and, on some points, controversial despite intensive research since the first discovery of p62 mutations in Paget’s disea…”
BackgroundSQSTM-1/p62 potentiates HTLV-1 Tax-mediated NF-κB activation through its ubiquitin binding function
Schwob, A., Teruel, É., Dubuisson, L., Lormières, F., Verlhac, P., Abudu, Y. P., Gauthier, J., Naoumenko, M., Cloarec-Ung, F.-M., Faure, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-52408-x · Cited by 30
Genetic Determinants of Paget’s Disease of Bone
Makaram, N. S., & Ralston, S. H. (2021) · Current Osteoporosis Reports · doi:10.1007/s11914-021-00676-w · Cited by 34
“Researchers in Quebec identified a proline to leucine mutation at codon 392 of the protein (P392L) as a cause of the disease [61], and soon after, this and other mutations were identified in the ubiquitin-associated (UBA) domain as the cause of the disease in people of UK descent [62].”
BackgroundSun, Q., Sammut, B., Wang, F., Kurihara, N., Windle, J. J., Roodman, G. D., & Galson, D. L. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2026 · Cited by 30
“The most common mutation is p62, an autosomal dominant mutation with variable penetrance.((6)) However, mutant p62 alone does not appear to be capable of inducing Paget’s disease of bone because we found that mice with the murine equivalent of p62 (p62) knocked‐in or overexpressing p62 have increased osteoclast number…”
Backgroundp62 mutations, ubiquitin recognition and Paget's disease of bone
Layfield, R., Cavey, J. R., Najat, D., Long, J., Sheppard, P. W., Ralston, S. H., & Searle, M. S. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340735 · Cited by 33
Updates on Paget’s Disease of Bone
Choi, Y. J., Sohn, Y. B., & Chung, Y. (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2022.1575 · Cited by 32
“A recurrent mutation that changes proline to leucine at codon 392 (P392L) was originally reported in the French-Canadian population [43].”
BackgroundRendina, D., Falchetti, A., Diacinti, D., Bertoldo, F., Merlotti, D., Giannini, S., Cianferotti, L., Girasole, G., Monaco, M. D., Gonnelli, S., et al. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02318-1 · Cited by 29
Beyond dystonia and ataxia: Expanding the phenotype of SQSTM1 mutations
Zúñiga‐Ramírez, C., de Oliveira, L. M., Kramis-Hollands, M., Algarni, M., Soto-Escageda, A., Sáenz‐Farret, M., González-Usigli, H., & Fasano, A. A. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.12.031 · Cited by 26
Roles of Stress Response in Autophagy Processes and Aging-Related Diseases
Watanabe, Y., Taguchi, K., & Tanaka, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813804 · Cited by 31
Ke, Y., Yue, H., He, J., Liu, Y., & Zhang, Z. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.90 · Cited by 26
Specific Regulation of Cytokine-Dependent p38 MAP Kinase Activation by p62/SQSTM1
Kawai, K., Saito, A., SUDO, T., & Osada, H. (2007) · The Journal of Biochemistry · doi:10.1093/jb/mvn027 · Cited by 32
Stephens, E., Roy, M., Bisson, M., Nguyen, H. D., Scott, M. S., Boire, G., Bouchard, L., & Roux, S. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165852 · Cited by 25
Falchetti, A., Masi, L., & Brandi, M. L. (2010) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32833af61e · Cited by 26
Divisato, G., di Carlo, F. S., Petrillo, N., Esposito, T., & Gianfrancesco, F. (2018) · Clinical Genetics · doi:10.1111/cge.13247 · Cited by 26
Cronin, O., Forsyth, L., Goodman, K., Lewis, S. C., Keerie, C., Walker, A., Porteous, M. E., Cetnarskyj, R., Ranganath, L. R., Selby, P. L., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-030689 · Cited by 25
Paget’s Disease of Bone: Osteoimmunology and Osteoclast Pathology
Rabjohns, E. M., Hurst, K., Ghosh, A., Cuéllar‐Gutiérrez, M. C., Rampersad, R. R., & Tarrant, T. K. (2021) · Current Allergy and Asthma Reports · doi:10.1007/s11882-021-01001-2 · Cited by 27
Llewellyn, K. J., Nalbandian, A., Jung, K., Nguyen, C., Avanesian, A., Mozaffar, T., Piomelli, D., & Kimonis, V. E. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt523 · Cited by 25
Ubiquitin-mediated signalling and Paget's disease of bone
Layfield, R., & Shaw, B. (2007) · BMC Biochemistry · doi:10.1186/1471-2091-8-s1-s5 · Cited by 26
“These mutations include five truncating mutations that delete most or all of the UBA domain, and seven missense mutations located within the UBA domain [22,25-30].”
BackgroundTuck, S. P., & Walker, J. (2020) · Clinical Medicine · doi:10.7861/clinmed.20.6.page · Cited by 25
Peters, S., & Meylan, E. (2013) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32835d720b · Cited by 23
Gene expression profile in osteoclasts from patients with Paget's disease of bone
Michou, L., Chamoux, E., Couture, J., Morissette, J., Brown, J. P., & Roux, S. (2009) · Bone · doi:10.1016/j.bone.2009.11.012 · Cited by 31
“Among the seven loci reported, the 5q35-qter region is the only one for which a gene has been identified, namely the Sequestosome1 gene (SQSTM1) that encodes the p62 protein [8].”
BackgroundSelf-citationGenetic association study of UCMA/GRP and OPTN genes (PDB6 locus) with Paget's disease of bone
Michou, L., Conceição, N., Morissette, J., Gagnon, É., Miltenberger-Miltényi, G., Siris, E. S., Brown, J. P., & Cancela, M. L. (2012) · Bone · doi:10.1016/j.bone.2012.06.028 · Cited by 23
“Clinical characteristics of these cohorts were previously published [3, 5, 21].”
BackgroundSelf-citationSeibenhener, M. L., Zhao, T., Du, Y., Calderilla-Barbosa, L., Yan, J., Jiang, J., Wooten, M. W., & Wooten, M. C. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.04.006 · Cited by 22
Human Genetics of Sclerosing Bone Disorders
Ridder, R. D., Boudin, E., Mortier, G. R., & Hul, W. V. (2018) · Current Osteoporosis Reports · doi:10.1007/s11914-018-0439-7 · Cited by 24
Autophagy and 3-Phosphoinositide-Dependent Kinase 1 (PDK1)-Related Kinome in Pagetic Osteoclasts
McManus, S., Bisson, M., Chamberland, R., Roy, M., Nazari, S., & Roux, S. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2806 · Cited by 26
“Around 30 SQSTM1mutations have been reported, but the p62 P392L substitution remains the most prevalent.((8,9)) Nevertheless, the majority of patients with PDB do not carry SQSTM1 mutations, thus other genetic or environmental contributors are likely also involved.”
BackgroundPost-fertilisation sperm mitophagy: the tale of Mitochondrial Eve and Steve
Šutovský, P., & Song, W. (2017) · Reproduction Fertility and Development · doi:10.1071/rd17364 · Cited by 25
Nagy, Z. B., Gergely, P., Donáth, J., Borgulya, G., Csanád, M., & Poór, G. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.071021 · Cited by 26
Beyens, G., Wuyts, W. A., Cleiren, E., de Freitas, F., Tiegs, R. D., & Hul, W. V. (2006) · Calcified Tissue International · doi:10.1007/s00223-006-0122-3 · Cited by 23
“Primers for exon 8 are identical to those in [34].”
BackgroundEffect of genetic variants of OPTN in the pathophysiology of Paget's disease of bone
Silva, I. A. L., Conceição, N., Gagnon, É., Caiado, H., Brown, J. P., Gianfrancesco, F., Michou, L., & Cancela, M. L. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.10.008 · Cited by 23
Self-citationWu, J., Hou, S., Yang, L., Wang, Y., Wen, C., Guo, Y., Luo, S., Fang, H., Jiao, H., Xu, H., et al. (2023) · Aquatic Toxicology · doi:10.1016/j.aquatox.2023.106398 · Cited by 20
The S349T mutation of SQSTM1 links Keap1/Nrf2 signalling to Paget's disease of bone
Wright, T., Rea, S. L., Goode, A., Bennett, A. J., Ratajczak, T., Long, J., Searle, M. S., Goldring, C. E., Park, B. K., Copple, I. M., et al. (2012) · Bone · doi:10.1016/j.bone.2012.10.023 · Cited by 28
“The condition has a strong genetic element and numerous mutations affecting the Sequestosome 1 (SQSTM1) gene, which encodes the SQSTM1 (also known as p62) protein, have been identified in patients with familial and sporadic PDB [3–5].”
BackgroundOsteoclast Biology: Regulation of Formation and Function
Choi, Y., Faccio, R., Teitelbaum, S. L., & Takayanagi, H. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800571-2.00004-9 · Cited by 25
Inclusion Body Myopathy with Paget Disease of Bone and/or Frontotemporal Dementia
Kimonis, V. E. (2007) · eScholarship (California Digital Library) · Cited by 21
Metadata
- Authors
- Laurin, N., Brown, J. P., Morissette, J., & Raymond, V.
- Affiliations
- Centre hospitalier de l'Université Laval (CA)
- Corresponding author
- Raymond, Vincent
- ORCID
- Brown, Jacques P.
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2002-06
- Volume
- 70
- Issue
- 6
- Pages
- 1582-1588
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC379146
- OpenAlex
- W2011308707
- Cited by
- 563
- References
- 47
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 10 · 2023: 23 · 2022: 14 · 2021: 19 · 2020: 26 · 2019: 25 · 2018: 19 · 2017: 14 · 2016: 34 · 2015: 28 · 2014: 35 · 2013: 30 · 2012: 31
- FWCI
- 7.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4066 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fonds pour la Formation de Chercheurs et l'Aide à la Recherche
- Canadian Institutes of Health Research (MOP-3804)
- Fonds de Recherche du Québec - Santé
- Canada Foundation for Innovation (548)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Alkaline Phosphatase Research Studies
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone Tumor Diagnosis and Treatments
- Keywords
- Paget's disease of bone, p62, recurrent mutations, ubiquitin-associated domain, haplotype mapping, French-Canadian families, NF-κB signaling, genetic susceptibility, bone turnover
- MeSH terms
- Sequestosome-1 Protein, Base Sequence, Canada, Carrier Proteins, France, Genetic Testing, Haplotypes, Heterozygote, Homozygote, Humans, Molecular Sequence Data, Mutation, Osteitis Deformans, Proteins, Adaptor Proteins, Signal Transducing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.